When it comes to biotech investing, North Carolina still lags the big players out West and in the Northeast. However, this state does have some active investors. Durham-based Hatteras Venture Partners invested an estimated $38.5 million last year. Pappas Ventures, also in Durham, invested $22.8 million and Intersouth Partners invested $13.4 million, according to estimates published by pharma industry tracking startups Endpoints, which used Thomson Reuters data for its estimates. Note: Endpoints…
from Charlotte Business News - Local Charlotte News | Charlotte Business Journal http://www.bizjournals.com/charlotte/news/2016/06/22/tar-heel-state-vcs-lag-california-massachusetts-in.html?ana=RSS%26s=article_search
No comments:
Post a Comment